These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 171797)

  • 21. Comparison of the effects of histamine and tolazoline on the inotropic, chronotropic and cyclic AMP producing effects in the guinea pig heart.
    Verma SC; McNeill JH
    Proc West Pharmacol Soc; 1977; 20():409-14. PubMed ID: 197546
    [No Abstract]   [Full Text] [Related]  

  • 22. Positive inotropic activity of cholera enterotoxin on the embryonic chick heart.
    Hedtke JL; Shideman FE; Goldberg ND
    J Pharmacol Exp Ther; 1976 Apr; 197(1):27-37. PubMed ID: 177757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covariance of myocardial cyclic AMP and calcium during beta-adrenergic stimulation in vivo.
    Bloom S; Sweat FW
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):505-14. PubMed ID: 4152820
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of homologous thrombin and fibrinogen degradation products on fibrinogen synthesis in rabbits.
    Kessler CM; Bell WR
    J Lab Clin Med; 1979 May; 93(5):768-82. PubMed ID: 219123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of tolbutamide on contractility and cyclic adenosine 3':5'-monophosphate concentration in the intact beating rat heart.
    Brown JD; Brown ME
    J Pharmacol Exp Ther; 1977 Jan; 200(1):166-73. PubMed ID: 189007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
    Nieuwenhuizen W; Emeis JJ; Vermond A
    Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cyclic AMP accumulation in dog heart washed particle preparations by aprotinine.
    Cros GH; Katz S; McNeill JH
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):255-66. PubMed ID: 6156476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-dependent nature of the interaction of fibrinogen-degradation products and 5-hydroxytryptamine on various vascular smooth muscle preparations [proceedings].
    Forster C; Mohan J; Whalley ET
    Br J Pharmacol; 1980 Jan; 68(1):151P. PubMed ID: 7357163
    [No Abstract]   [Full Text] [Related]  

  • 29. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen.
    Sueishi K; Nanno S; Tanaka K
    Thromb Haemost; 1981 Feb; 45(1):90-4. PubMed ID: 7245130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of amrinone on contractile activities, cyclic nucleotides and adenyl cyclase activity of cultured rat heart cells].
    Li XJ; Wang DS; Chen XZ
    Zhongguo Yao Li Xue Bao; 1987 Sep; 8(5):429-33. PubMed ID: 2835886
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of adenylate cyclase-cyclic AMP in cardiac actions of adrenergic amines.
    Drummond GI; Hemmings SJ
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():213-22. PubMed ID: 4377596
    [No Abstract]   [Full Text] [Related]  

  • 32. Possible involvement of cyclic adenosine 3':5'-monophosphate in the genesis of catecholamine-induced tachycardia in isolated rabbit sinoatrial node.
    Taniguchi T; Fujiwara M; Ohsumi K
    J Pharmacol Exp Ther; 1977 Jun; 201(3):678-88. PubMed ID: 194027
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of papaverine on cyclic AMP, calcium uptake and force of contraction in isolated guinea-pig auricles.
    Holzmann S; Meinertz T; Nawrath H; Scholz H
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):443-50. PubMed ID: 191880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationships of vasoactive peptides derived from fibrin or fibrinogen degraded by plasmin.
    Belew M; Gerdin B; Lindeberg G; Porath J; Saldeen T; Wallin R
    Biochim Biophys Acta; 1980 Feb; 621(2):169-78. PubMed ID: 7353036
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of products of fibrinogen digestion by plasmin (P-FDP) on the central nervous system.
    Wiśniewski K; Buczko W; Moniuszko-Jakoniuk J
    Acta Neurobiol Exp (Wars); 1975; 35(3):275-83. PubMed ID: 126007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic AMP mediation of the excitatory effect of serotonin in the heart of Aplysia.
    Mandelbaum DE; Koester J; Schonberg M; Weiss KR
    Brain Res; 1979 Nov; 177(2):388-94. PubMed ID: 227537
    [No Abstract]   [Full Text] [Related]  

  • 37. Proceedings: Positive chronotropic effect of dialysable peptides derived from plasmin digestion of bovine fibrinogen preparations. Role of cyclic AMP.
    Buckzo W; Franco R; Bianchetti G; Donati MB; de Gaetano G
    Thromb Diath Haemorrh; 1975 Sep; 34(1):351-2. PubMed ID: 171797
    [No Abstract]   [Full Text] [Related]  

  • 38. Positive chronotropic effect of dialysable peptides derived from plasmin digestion of bovine fibrinogen preparations.
    Buczko W; Franco R; Bianchetti G; Donati MB; de Gaetano G; Garattini S
    Eur J Pharmacol; 1976 Apr; 36(2):355-61. PubMed ID: 179824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of fibrinogen degradation products (FDP) on heart rate and some metabolic parameters in the rat.
    Buczko W
    Acta Physiol Pol; 1978; 29(3):259-66. PubMed ID: 707144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of fibrinogen degradation products (FDP) on the ATPase activity in the rat heart.
    Buczko W
    Acta Physiol Pol; 1978; 29(2):185-7. PubMed ID: 148831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.